Showing results (91-100 of 231) with videos related to
Sort By:
Pageof 24
Dermatology and Therapy|July 29, 2025
Brodalumab: Seven-Year US Pharmacovigilance ReportMark G Lebwohl, John Y Koo, April W Armstrong, et al.Dermatology and Therapy|May 9, 2024
Brodalumab: 5-Year US Pharmacovigilance ReportMark G Lebwohl, John Y Koo, April W Armstrong, et al.European Journal of Radiology|August 21, 2009
Pelvic digital subtraction catheter angiography--are routine oblique projections necessary?Neil Rane, Atique Imam, Peter Foley, et al.Archives of Dermatology|March 8, 2003
The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap)Peter Foley, Yeqin Zuo, Anne Plunkett, et al.The Australasian Journal of Dermatology|March 3, 2025
Drug Survival of Biological Therapies in Smokers and Non-Smokers With Psoriasis: A Retrospective Cohort Study Using Data From the Australasian Psoriasis RegistryFerial May, Julie Armstrong, Sara Vogrin, et al.Dermatologic Therapy|September 10, 2021
Pityriasis rubra pilaris treatment options: A retrospective case series from a tertiary hospitalSarah Ringin, Christopher S Baker, Peter Foley, et al.The Australasian Journal of Dermatology|August 9, 2021
Combination treatment with monoclonal antibodies: Secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthmaPatrick D Mahar, Celia M Zubrinich, Nick Manuelpillai, et al.The Journal of Dermatological Treatment|September 14, 2007
Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) studyAlice B Gottlieb, Leon Kircik, Drore Eisen, et al.The Australasian Journal of Dermatology|May 25, 2011
Thirty-five units of botulinum toxin type A for treatment of axillary hyperhidrosis in female patientsStefanie Marcella, Greg Goodman, Simon Cumming, et al.The Australasian Journal of Dermatology|March 31, 2021
SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology GroupCharlie Wang, Marius Rademaker, Bruce Tate, et al.Pageof 24